LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.
Actins
/ genetics
Adult
Animals
Antibodies, Neutralizing
/ pharmacology
Becaplermin
/ antagonists & inhibitors
Case-Control Studies
Cell Dedifferentiation
/ genetics
Cell Proliferation
/ drug effects
Collagen Type I
/ genetics
Disease Models, Animal
Familial Primary Pulmonary Hypertension
/ chemically induced
Female
Fibronectins
/ genetics
Gene Expression Regulation
Homeostasis
/ genetics
Humans
Integrin beta1
/ genetics
Low Density Lipoprotein Receptor-Related Protein-1
/ antagonists & inhibitors
Male
Mice
Middle Aged
Monocrotaline
/ administration & dosage
Myocytes, Smooth Muscle
/ drug effects
Nuclear Proteins
/ genetics
Pulmonary Artery
/ drug effects
RNA, Small Interfering
/ genetics
Rats
Receptors, Platelet-Derived Growth Factor
/ genetics
Signal Transduction
Tissue Culture Techniques
Trans-Activators
/ genetics
Cell proliferation
Low density lipoprotein receptor-related protein 1
Pulmonary hypertension
Smooth muscle cell phenotype
β1-integrin
Journal
Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730
Informations de publication
Date de publication:
01 06 2019
01 06 2019
Historique:
received:
19
10
2018
revised:
19
03
2019
accepted:
20
03
2019
pubmed:
27
3
2019
medline:
6
2
2020
entrez:
27
3
2019
Statut:
ppublish
Résumé
Pulmonary hypertension (PH) is characterized by a thickening of the distal pulmonary arteries caused by medial hypertrophy, intimal proliferation and vascular fibrosis. Low density lipoprotein receptor-related protein 1 (LRP1) maintains vascular homeostasis by mediating endocytosis of numerous ligands and by initiating and regulating signaling pathways. Here, we demonstrate the increased levels of LRP1 protein in the lungs of idiopathic pulmonary arterial hypertension (IPAH) patients, hypoxia-exposed mice, and monocrotaline-treated rats. Platelet-derived growth factor (PDGF)-BB upregulated LRP1 expression in pulmonary artery smooth muscle cells (PASMC). This effect was reversed by the PDGF-BB neutralizing antibody or the PDGF receptor antagonist. Depletion of LRP1 decreased proliferation of donor and IPAH PASMC in a β1-integrin-dependent manner. Furthermore, LRP1 silencing attenuated the expression of fibronectin and collagen I and increased the levels of α-smooth muscle actin and myocardin in donor, but not in IPAH, PASMC. In addition, smooth muscle cell (SMC)-specific LRP1 knockout augmented α-SMA expression in pulmonary vessels and reduced SMC proliferation in 3D ex vivo murine lung tissue cultures. In conclusion, our results indicate that LRP1 promotes the dedifferentiation of PASMC from a contractile to a synthetic phenotype thus suggesting its contribution to vascular remodeling in PH.
Identifiants
pubmed: 30910704
pii: S0925-4439(19)30086-9
doi: 10.1016/j.bbadis.2019.03.012
pii:
doi:
Substances chimiques
ACTA2 protein, human
0
Actins
0
Antibodies, Neutralizing
0
Collagen Type I
0
Fibronectins
0
Integrin beta1
0
LRP1 protein, human
0
Low Density Lipoprotein Receptor-Related Protein-1
0
Nuclear Proteins
0
RNA, Small Interfering
0
Trans-Activators
0
myocardin
0
Becaplermin
1B56C968OA
Monocrotaline
73077K8HYV
Receptors, Platelet-Derived Growth Factor
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1604-1616Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.